Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
myBrain Technologies
Paris, Île-de-France, France
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
myBrain Technologies has commercialized Melomind, an EEG-based neurofeedback headset and mobile application that uses real-time brain activity monitoring to help users manage stress through auditory feedback loop training.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Physiological Monitoring
02
Partnerships
Institut du Cerveau et de la Moelle épinière (ICM)
Beyond the preview
Go deeper on myBrain Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myBrain Technologies.